Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CFTR2 | RCV000007547 | SCV000087509 | pathogenic | Cystic fibrosis | 2017-03-17 | reviewed by expert panel | research | |
Baylor Genetics | RCV001004480 | SCV001163525 | pathogenic | Cystic fibrosis; Congenital bilateral aplasia of vas deferens from CFTR mutation | criteria provided, single submitter | clinical testing | ||
CFTR- |
RCV000007547 | SCV001169501 | pathogenic | Cystic fibrosis | 2018-01-29 | criteria provided, single submitter | curation | |
Johns Hopkins Genomics, |
RCV000007547 | SCV001425310 | pathogenic | Cystic fibrosis | 2020-03-09 | criteria provided, single submitter | clinical testing | Disease-causing CFTR variant. See www.CFTR2.org for phenotype information. |
Labcorp Genetics |
RCV000007547 | SCV001583394 | pathogenic | Cystic fibrosis | 2022-04-24 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Trp846*) in the CFTR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CFTR are known to be pathogenic (PMID: 1695717, 7691345, 9725922). This variant is present in population databases (rs267606722, gnomAD 0.0009%). This premature translational stop signal has been observed in individuals with CFTR-related conditions (PMID: 2210768, 7689897, 23974870, 25122143, 28603918). ClinVar contains an entry for this variant (Variation ID: 7127). |
Baylor Genetics | RCV004566689 | SCV005057470 | pathogenic | Bronchiectasis with or without elevated sweat chloride 1 | 2023-11-28 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000007547 | SCV000027748 | pathogenic | Cystic fibrosis | 1990-09-01 | no assertion criteria provided | literature only | |
Counsyl | RCV000007547 | SCV001132146 | pathogenic | Cystic fibrosis | 2015-08-04 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001826430 | SCV002080762 | pathogenic | CFTR-related disorder | 2017-03-17 | no assertion criteria provided | clinical testing |